Join the club for FREE to access the whole archive and other member benefits.

Martin Borch Jensen

CSO at Gordian Biotechnology.

Fundamental biological processes cause physiological decline with age, and are the #1 risk factor for most diseases in the developed world. Successfully modifying these thus represents the highest leverage we have for biomedically alleviating human disease, and recent research has demonstrated that this is in fact possible. I spend my time moving us closer to that goal, previously through academic research and public engagement, now as a biotech entrepreneur.

Visit website: http://www.martinborchjensen.com/

 martinborchjensen

 MartinBJensen

See also: Company Gordian Biotechnology - Pioneering a novel discovery platform to radically improve drug development for complex diseases of aging.

Details last updated 24-Apr-2021

Martin Borch Jensen is also referenced in the following:

ARDD 2021 - 8th Aging Research and Drug Discovery Meeting

31-Aug-2021 to 03-Sep-2021

Online event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen chaired by Morten Scheibye-Knudsen, Daniela Bakula and Alex Zhavoronkov, and with many speakers.

ARDD 2022 - 9th Aging Research and Drug Discovery Meeting

29-Aug-2022 to 02-Sep-2022

Event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen